In light of the COVID-19 pandemic, connecting rare disease stakeholders and advancing meaningful dialogue is now more critical than ever to improving the lives of more than 25 million Americans impacted by over 7,000 rare diseases. As technology in rare disease accelerates, we must act now to drive innovation, collaborate for better outcomes, and assure access to care for all. The 2020 NORD Rare Diseases & Orphan Products Breakthrough Summit, which will be presented as a virtual event, will feature timely topics including the COVID-19 pandemic’s impact on the rare disease community, drug pricing, advancements in technology, tools for accelerating rare disease cures and more. A blue-ribbon panel of public health experts, including leaders from FDA and NIH, patient advocates, and industry KOLs will discuss how to build a stronger healthcare system from what we’ve learned this year. One-on-one networking opportunities with rare disease innovators will make the 2020 NORD Summit an event not to miss. Be sure to visit www.nordsummit.org for an agenda and to register.